Dr. Reddy's Laboratories Limited

DB:RDDA Stock Report

Market Cap: €9.6b

Dr. Reddy's Laboratories Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Erez Israeli

Chief executive officer

₹230.3m

Total compensation

CEO salary percentagen/a
CEO tenure8.2yrs
CEO ownershipn/a
Management average tenure2.4yrs
Board average tenure4.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Erez Israeli's remuneration changed compared to Dr. Reddy's Laboratories's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2026₹230mn/a

₹43b

Dec 31 2025n/an/a

₹57b

Sep 30 2025n/an/a

₹59b

Jun 30 2025n/an/a

₹57b

Mar 31 2025₹175mn/a

₹57b

Dec 31 2024n/an/a

₹54b

Sep 30 2024n/an/a

₹53b

Jun 30 2024n/an/a

₹56b

Mar 31 2024₹197mn/a

₹56b

Dec 31 2023n/an/a

₹52b

Sep 30 2023n/an/a

₹51b

Jun 30 2023n/an/a

₹47b

Mar 31 2023₹195mn/a

₹45b

Dec 31 2022n/an/a

₹36b

Sep 30 2022n/an/a

₹31b

Jun 30 2022n/an/a

₹30b

Mar 31 2022₹127mn/a

₹24b

Dec 31 2021n/an/a

₹26b

Sep 30 2021n/an/a

₹19b

Jun 30 2021n/an/a

₹17b

Mar 31 2021₹120mn/a

₹17b

Dec 31 2020n/an/a

₹21b

Sep 30 2020n/an/a

₹15b

Jun 30 2020n/an/a

₹19b

Mar 31 2020₹195m₹107m

₹19b

Compensation vs Market: Erez's total compensation ($USD2.42M) is below average for companies of similar size in the German market ($USD5.55M).

Compensation vs Earnings: Erez's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Erez Israeli (58 yo)

8.2yrs
Tenure
₹230,330,000
Compensation

Mr. Erez Israeli, MBA has been Chief Executive Officer of Dr. Reddy's Laboratories Limited since August 1, 2019 and has been its Member of the Management Council since April 02, 2018. Mr. Israeli served as...

Leadership Team

NamePositionTenureCompensationOwnership
Gunupati Prasad
Co-Chairman40.2yrs₹158.17m13.07%
€ 1.3b
Kallam Reddy
Chairman of the Board & Member of the Management Council33.4yrs₹100.66m13.61%
€ 1.3b
Erez Israeli
CEO & Member of the Management Council8.2yrs₹230.33mno data
Mannam Venkatanarasimham
CFO & Member of the Management Council1.8yrs₹72.48m0.0074%
€ 709.6k
Krishna Venkatesh
Global Head of IPDO2.4yrs₹41.18mno data
Deepak Sapra
Global Head of Pharmaceutical Services and Active Ingredients & Member of Management Councilno data₹50.89m0.0091%
€ 875.5k
Motupalli Ramana
CEO of Global Generics & Member of Management Councilno data₹89.25m0.0082%
€ 789.7k
Sanjay Sharma
Executive VP8.8yrs₹71.07mno data
Patrick Aghanian
Head of Consumer Health Organization & Member of Management Councilno data₹107.54mno data
Bhethanabottla Phanimitra
Chief Digital & Information Officer and Member of the Management Council2.8yrs₹37.54m0.0010%
€ 101.2k
Milan Kalawadia
CEO of North America & Member of Management Council2.1yrs₹86.78m0.0057%
€ 547.7k
M S Sundar
Global Head of Quality and PV & Member of Management Councilless than a yearno data0.0043%
€ 412.7k
2.4yrs
Average Tenure
57yo
Average Age

Experienced Management: RDDA's management team is considered experienced (2.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gunupati Prasad
Co-Chairman40.2yrs₹158.17m13.07%
€ 1.3b
Kallam Reddy
Chairman of the Board & Member of the Management Council33.4yrs₹100.66m13.61%
€ 1.3b
Claudio Albrecht
Independent Director3.1yrs₹20.24mno data
Arun Kumar
Independent Director3.8yrs₹22.14mno data
Shikha Sharma
Independent Director7.4yrs₹16.45mno data
Leo Puri
Lead Independent Director7.7yrs₹22.62mno data
Kodumudi Krishnan
Independent Director4.4yrs₹14.18mno data
Sanjiv Mehta
Independent Director2.5yrs₹17.40mno data
Alpna Seth
Independent Director3.4yrs₹19.77mno data
Penny Wan
Independent Director4.4yrs₹20.72mno data
4.4yrs
Average Tenure
66yo
Average Age

Experienced Board: RDDA's board of directors are considered experienced (4.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/12 09:41
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dr. Reddy's Laboratories Limited is covered by 69 analysts. 37 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit Bhat360 ONE Capital Market Private Limited
Gaurav TinaniAmbit Capital
null nullAnand Rathi Shares and Stock Brokers Limited